CervoMed
CRVO
48 hedge funds and large institutions have $17.4M invested in CervoMed in 2025 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 12 increasing their positions, 15 reducing their positions, and 6 closing their positions.
50% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 6
7% more funds holding
Funds holding: 45 → 48 (+3)
1% more capital invested
Capital invested by funds: $17.3M → $17.4M (+$160K)
0.77% more ownership
Funds ownership: 23.05% → 23.82% (+0.77%)
20% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$486K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$151K |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$122K |
| 4 |
BAM
Byrne Asset Management
Kingston,
New Jersey
|
+$118K |
| 5 |
HF
HRT Financial
New York
|
+$115K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIC
AWM Investment Company
New York
|
-$551K |
| 2 |
HCM
Hilton Capital Management
Garden City,
New York
|
-$140K |
| 3 |
RAM
Readystate Asset Management
Chicago,
Illinois
|
-$118K |
| 4 |
Millennium Management
New York
|
-$90.3K |
| 5 |
TDC
Thompson Davis & Co
Richmond,
Virginia
|
-$55K |
CRVO Hedge Fund Activity: Q4 2025 in Review
48 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in CervoMed (CRVO) for Q4 2025, worth a combined $17.4M — up 0.93% from $17.3M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new CRVO positions and 6 closed out — a net gain of 3 holders — while 12 added to existing stakes and 15 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $486K. The largest seller was AWM Investment Company, cutting an estimated $551K.
- 48 institutional investors held CervoMed (CRVO) as of Q4 2025, up from 45 in Q3 2025.
- Funds reported $17.4M of CervoMed stock for Q4 2025, up 0.93% quarter-over-quarter.
- 9 funds opened new CervoMed positions in Q4 2025 and 6 closed out, a net change of +3 holders.
- The largest CervoMed buyer in Q4 2025 was Morgan Stanley, an estimated $486K added.
- The largest CervoMed seller in Q4 2025 was AWM Investment Company, an estimated $551K sold.
Based on aggregated 13F filings for Q4 2025.